How an Activist Group Helped Torpedo MDMA Therapy

Health
By Andrew Jacobs and Rachel Nuwer from NYT Health https://ift.tt/Rz9ZHik
via IFTTT Regulation and Deregulation of Industry, Psychedelic and Hallucinogenic Drugs, Ethics and Official Misconduct, Therapy and Rehabilitation, Veterans, Clinical Trials, Mental Health and Disorders, Psychiatry and Psychiatrists, Post-Traumatic Stress Disorder, Research, Drugs (Pharmaceuticals) The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda